RxElite Holdings, Inc. Be the First to Know!
Stock Guru Profile
This company has a dynamite plan for revenue that includes being the United States distributor of the most widely used inhalable anesthetic in the world: Sevoflurane for Minrad International.
* Market Size: Total addressable market from pipeline products exceed $2 Billion
* Sevoflurane is a $400 Million market in the US, with limited competitors;
* Market Growth: US Sevoflurane market growth is forecasted to be 11%-15% year over year (in volume);
Growth Strategy: Organic Growth Through
# A pipeline of more than ten specialty generic drugs with high barriers to entry
# Partnering agreements with low cost generic drug producers
We will be bringing you up to date on Sevoflurane this weekend and the muscle this brings to the RxElite business model.
Source: RxElite Holdings, Inc.
RxElite Holdings, Inc.
Ph: (208) 288-5550
Toll Free: (800) 414-1901
Fax: (208) 288-1191 Investor Relations
Charlie Forshee, 215-885-4981
investorrelations@rxelite.com
Segue Ventures LLCAbout RxElite Holdings, Inc.: RxElite Holdings, Inc. develops, manufactures, and markets generic prescription drug products in specialty generic markets. These markets include products in the areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics, and injectable drugs), and transdermal patch products.
Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 involving known and unknown risks, delays, and uncertainties that may cause the our actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty of future financial results, our reliance on our sole supplier, the limited diversification of our product offerings, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.Disclosure: Pentony Enterprises LLC was compensated $18,000.00. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.Disclosure: StockGuru.com is owned and operated by Pentony Enterprises LLC,9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com.
Bookmark to:
Add ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to Del.icio.usAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to diggAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to FURLAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to blinklistAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to redditAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to Feed Me LinksAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to TechnoratiAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to Yahoo My WebAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to NewsvineAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to SocializerAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to Ma.gnoliaAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to Stumble UponAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to Google Bookmarks
Add ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to RawSugarAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to SquidooAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to SpurlAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to BlinkBitsAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to NetvouzAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to RojoAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to BlogmarksAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to ShadowsAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to SimpyAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to Co.mmentsAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to ScuttleAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to BloglinesAdd ‘StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)’ to Tailrank